These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Clinical significance of the detection of thymidine phosphorylase activity in esophageal squamous cell carcinomas. Ikeguchi M, Oka S, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N. Eur Surg Res; 1999 Apr; 31(4):357-63. PubMed ID: 10449995 [Abstract] [Full Text] [Related]
15. Thymidine phosphorylase and breast carcinoma. Yang Q, Yoshimura G, Mori I, Sakurai T, Kakudo K. Anticancer Res; 2002 Apr; 22(4):2355-60. PubMed ID: 12174926 [Abstract] [Full Text] [Related]
16. Prognostic significance of platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in stage pT1 G3 bladder cancer. Li S, Nomata K, Sawase K, Noguchi M, Kanda S, Kanetake H. Int J Urol; 2001 Sep; 8(9):478-82. PubMed ID: 11683966 [Abstract] [Full Text] [Related]
19. Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma. Konno S, Takebayashi Y, Aiba M, Akiyama S, Ogawa K. Cancer Lett; 2001 May 10; 166(1):103-11. PubMed ID: 11295293 [Abstract] [Full Text] [Related]